Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Telomere Biology Disorders: early-phase trial registry
3 of 4 indexed Telomere Biology Disorders trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Telomere Biology Disorders: 4 US clinical trials tracked, 3 recruiting.
Telomere Biology Disorders is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Suneet Agarwal, running 1 of these trials.
Enrollment posture brief
Registry condition telomere-biology-disorders
OPEN 3 | RECR 75% | LATE 0 | EARLY 2 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Telomere Biology Disorders lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Telomere Biology Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Telomere Biology Disorders is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
National Heart, Lung, and Blood Institute (NHLBI)
NCT05012111
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
Masonic Cancer Center, University of Minnesota
NCT03579875
Nucleoside Therapy in Patients With Telomere Biology Disorders
Suneet Agarwal
NCT06817590
Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders (TBD)
National Cancer Institute (NCI)
NCT04959188
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Telomere Biology Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Telomere Biology Disorders trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Telomere Biology Disorders page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Telomere Biology Disorders trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Suneet Agarwal sponsors the most Telomere Biology Disorders trials on record, review their full trial history before evaluating a specific study. See Suneet Agarwal's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Telomere Biology Disorders condition card totals 4 registered trials; most-linked intervention Donor mobilized PBSC infusion; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.